The global anti-aging market size was valued at USD 53.16 billion in 2025 and is projected to grow from USD 56.63 billion in 2026 to USD 93.86 billion by 2034, registering a CAGR of 6.52% during the forecast period (2026–2034). North America dominated the anti-aging market with a share of 36.82% in 2025.
Anti-aging products, treatments, and technologies are designed to reduce visible signs of aging and support healthier-looking skin and appearance. Anti-aging products and treatments are generally tracked under HSN Code 3304 (beauty or make-up preparations and preparations for the care of the skin) and SIC Code 2844 (Perfumes, Cosmetics, and Other Toilet Preparations).
The anti-aging market demand is driven by the focus on youthful appearance and the increasing demand for solutions that reduce visible signs of aging across different age groups. The adoption of cosmetic procedures and advanced aesthetic treatments contributes to the anti-aging market growth.
By Product
By Distribution Channel
Download a Free Sample To learn more about this report,
Shift toward Collagen-Boosting Anti-Aging Treatments
The anti-aging market analysis shows a shift toward the interest in maintaining youthful skin, which is increasing demand for treatments and products that support collagen production. Peptides, retinol, vitamin C, and other active ingredients are being used to improve skin firmness, elasticity, and the appearance of fine lines. This trend is encouraging anti-aging brands to focus on solutions that support the skin’s natural collagen-building process.
Expansion of Next-Generation Dermal Fillers
The demand for non-surgical facial rejuvenation is supporting the development of advanced dermal fillers with improved texture, longer-lasting effects, and more natural-looking results. New formulations are increasingly designed to restore facial volume while maintaining normal facial movement and appearance. This trend is expanding the use of injectable anti-aging treatments for areas such as the cheeks, lips, jawline, and under-eye region.
Supply chain disruptions are expected to have a moderate impact on the anti-aging market share due to dependence on active ingredients, botanical extracts, specialty chemicals, packaging materials, and global manufacturing and distribution networks. The market is expected to follow a U-shaped recovery, as shortages of cosmetic ingredients, packaging delays, higher transportation costs, and manufacturing constraints can prolong supply disruptions before product availability and distribution return to stable levels. The market is expected to grow at a CAGR of 6.52%, but supply chain constraints could approximately lower this by 1.2 percentage points, resulting in short-term growth of around 5.32%. As supply conditions normalize through improved ingredient availability, stable packaging supplies, expanded manufacturing capacity, and smoother logistics, anti-aging market growth is expected to gradually return to 6.52%.
The anti-aging market forecasts investments directed toward science-backed skincare formulations, premium beauty brands, R&D capabilities, and personalized products.
Key Investment and Funding Activities in Anti-Aging Market, 2025–2026
Be Clinical
USD 2.4 million
In August 2026, Be Clinical raised USD 2.4 million in a seed funding round led by Sauce, with participation from V3 Ventures and angel investors.
OneSkin
USD 20 million in Series A investment
In August 2025, OneSkin secured USD 20 million in Series A investment from Prelude Growth Partners to accelerate development and commercialization of its skin-longevity products.
Debut
USD 20 million
In August 2025, Debut raised USD 20 million to expand its AI-based ingredient-discovery platform for skin longevity, focusing on next-generation cosmetic ingredients that target biological hallmarks of aging.
Demand for Botulinum Toxin Treatment and Aesthetic Medicine Adoption Drives Market
The demand for botulinum toxin treatments is increasing as consumers seek non-surgical options for facial wrinkle reduction and fine lines. Short treatment times and limited recovery requirements make these procedures attractive to a wider consumer group. This preference for quick and minimally invasive wrinkle treatments is strengthening demand in the anti-aging market.
The expansion of aesthetic medicine is increasing demand for non-invasive and minimally invasive anti-aging treatments. Consumers are seeking procedures that improve skin appearance, facial volume, and signs of aging without major surgery. Advances in injectables, skin treatments, and energy-based procedures are also expanding available treatment options. This wider range of aesthetic solutions is supporting market growth.
High Cost of Advanced Treatments and Misleading Product Claims Restrains Market Expansion
High costs of advanced anti-aging treatments can make them less affordable for many consumers. Procedures such as dermal fillers, laser treatments, and skin tightening often require specialized equipment and trained professionals. Multiple treatment sessions can further increase the overall expense for consumers.
Unclear or misleading claims about anti-aging products can make consumers uncertain about their effectiveness. Products may promise quick results or significant improvements without sufficient evidence to support these claims. This can reduce consumer trust and make buyers more cautious when choosing anti-aging products and treatments.
Growth of Anti-Aging Supplements and Professional Skin Rejuvenation Services Opens New Avenues for Market Players
Nutraceutical companies and wellness brands can target consumers seeking nutritional support for healthy aging and skin health. Products containing collagen peptides, antioxidants, vitamins, and other age-supporting ingredients can complement topical and aesthetic treatments. This creates revenue through supplement sales, premium formulations, subscription programs, and online distribution.
Aesthetic clinics, dermatology centers, and beauty providers can target consumers seeking professional solutions for wrinkles, pigmentation, uneven skin tone, and loss of skin firmness. Treatments such as chemical peels, laser resurfacing, and microneedling provide additional options beyond injectables. This creates revenue through treatment packages, repeat procedures, personalized skincare programs, and post-treatment product sales.
Limited Long-Term Treatment Results and Risk of Side Effects Hinders Market Growth
Many anti-aging treatments require repeated use to maintain visible results, while outcomes can vary between individuals. Differences in skin type, age, lifestyle, and treatment response can affect the duration and quality of results. This can make it difficult for providers and brands to maintain consistent customer expectations.
Anti-aging treatments such as injectables, chemical peels, laser procedures, and other aesthetic treatments can cause side effects such as irritation, swelling, redness, or skin sensitivity. In some cases, improper treatment or individual reactions may result in more serious complications. Concerns about these risks can make consumers more cautious about undergoing certain procedures.
The anti-wrinkle creams segment accounted for a share of 28.64% in 2025 due to the widespread use of topical anti-aging creams for reducing the appearance of fine lines, wrinkles, dryness, and uneven skin texture.
The serums segment is expected to grow at a CAGR of 8.21% during the forecast period, driven by increasing consumer interest in concentrated formulations targeting specific signs of skin aging. Their use of active ingredients such as retinol, vitamin C, niacinamide, and peptides makes them suitable for addressing fine lines, pigmentation, and loss of skin firmness.
Request Customizationto receive a tailored report.
The drugstores & retail pharmacies segment accounted for a share of 27.63% in 2025, owing to the accessibility of skincare products through established retail outlets and the availability of products from multiple brands.
The e-commerce segment is expected to grow at a CAGR of 9.18% during the forecast period, fueled by increasing online purchases of skincare products and the convenience of home delivery. Wider product availability, customer reviews, ingredient information, and easy comparison of different anti-aging formulations are also increasing online adoption.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by High Demand for Aesthetic Treatments and Advanced Skin Rejuvenation
The North America anti-aging market accounted for the largest regional share of 36.82% in 2025, supported by high consumer awareness of aesthetic procedures, widespread availability of dermatology and cosmetic clinics, and demand for minimally invasive treatments.
The U.S. anti-aging market is driven by the demand for botulinum toxin treatments, dermal fillers, and non-surgical facial rejuvenation as consumers seek visible results with limited downtime. In the U.S., the FDA has approved multiple botulinum toxin products, including Botox, Dysport, Xeomin, and Jeuveau, for temporary improvement of facial wrinkles, while FDA-approved dermal fillers are used to address facial lines and age-related volume loss.
The Canada anti-aging market is supported by increasing interest in Botox Cosmetic, hyaluronic acid dermal fillers, and other skin rejuvenation treatments for reducing wrinkles and restoring facial volume. Health Canada notes that hyaluronic acid products are the most commonly used dermal fillers in Canada, with more than 30 licensed HA dermal fillers, while Botox Cosmetic is approved as a prescription product.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Adoption of Skin Tightening Treatments and Acceptance of Emerging Treatments
The Asia Pacific anti-aging market is expected to grow at a CAGR of 8.45%, making it the fastest-growing regional market, supported by rising demand for antioxidant-based skincare, skin-tightening procedures, collagen stimulation, and regenerative aesthetics.
The China anti-aging market is benefitted by the growing adoption of HIFU skin tightening and regenerative aesthetics. Chinese companies such as Beijing QM Medical offer HIFU systems designed to stimulate collagen regeneration and improve skin firmness, while research from Chinese institutions is also examining adipose-derived progenitor-cell exosomes for reducing oxidative stress and cellular skin aging.
The India anti-aging market is increasingly incorporating regenerative aesthetics and antioxidant-focused approaches alongside conventional anti-aging procedures. The Association of Cutaneous Surgeons of India has specifically evaluated emerging treatments, including exosomes, polydeoxyribonucleotides (PDRNs), nanofat, and other regenerative approaches for dermatological applications.
The Japan anti-aging market is driven by growing interest in regenerative skincare, antioxidants, and treatments focused on improving skin quality rather than only reducing wrinkles. Galderma's introduction of Alastin regenerative skin care in Japan reflects increasing commercial interest in products designed around skin regeneration and quality improvement.
Europe: Strong Market Position Driven by Preference for Antioxidant-Based Skincare
The Europe anti-aging market is expected to grow at a CAGR of 5.78% during the forecast period, supported by increasing demand for antioxidant skincare, collagen stimulation, skin tightening, and regenerative aesthetic procedures.
The Germany anti-aging market is supported by the adoption of polynucleotide injections, radiofrequency skin tightening, microneedling, and biostimulator treatments. Recent clinical research at the University Medical Center Hamburg-Eppendorf has also evaluated radiofrequency microneedling for periorbital skin rejuvenation, reflecting growing clinical interest in energy-based skin tightening procedures.
The UK anti-aging market is witnessing strong interest in polynucleotides and other regenerative aesthetics, alongside established skin-tightening procedures. UK market players identify polynucleotides as one of the most actively discussed regenerative injectable categories, indicating consumer and practitioner interest in skin quality-focused anti-aging treatments.
Latin America: Market Shaped by Development of Regenerative Medicines
The Latin America anti-aging market is expected to grow at a CAGR of 6.37% during the forecast period. In Brazil, the International Society for Stem Cell Application (ISSCA) expanded its regenerative medicine activities in São Paulo through clinical training, international certification, and professional education. Mexico’s anti-aging market is expected to benefit from the country’s ageing population, with the Ministry of Health reporting around 18 million people aged 60 years and above in 2026 and projecting that one in five Mexicans will belong to this age group by 2050. The market is also supported by COFEPRIS’s ongoing regulatory framework for cosmetic products, including requirements for manufacturing practices, labeling, and commercialization of products intended to protect and maintain healthy skin.
Middle East & Africa: Market Development Supported by Focus on Healthy Ageing and Preventive Healthcare Measures
The Middle East & Africa anti-aging market is expected to grow at a CAGR of 6.12% during the forecast period. The UAE anti-aging market is supported by the country’s growing focus on healthy ageing. Dubai is strengthening its longevity ecosystem through the Dubai Longevity Authority to regulate and support longevity-related therapies, preventive interventions, clinical innovations, and investment across the sector, creating opportunities for advanced anti-aging and wellness products and services.
The National Department of Health expects the proportion of population above 60 years of age to reach 15.4% by 2050 in South Africa, increasing demand for healthy-ageing and age-management products and services. The market is also shaped by regulatory framework for cosmetics under the Foodstuffs, Cosmetics and Disinfectants Act, which controls the manufacture, sale, and importation of cosmetic products, supporting regulated commercialization of anti-aging skincare products.
The anti-aging market competitive landscape is highly fragmented, with established skincare companies, cosmetic brands, pharmaceutical companies, aesthetic treatment providers, and specialty product manufacturers. Key players such as L'Oréal S.A., The Estée Lauder Companies Inc., Procter & Gamble Company, Unilever PLC, and Beiersdorf AG, with these five companies estimated to account for approximately 25–30% of the global anti-aging market share.
Established players compete mainly through brand strength, product innovation, clinical research, broad product portfolios, premium formulations, and global distribution networks. Emerging and regional players focus in the anti-aging market ecosystem on specialized skincare products, personalized treatments, competitive pricing, natural ingredients, digital channels, and targeted anti-aging solutions.
September 2026: Blackstone began exploring a potential sale of ZO Skin Health at a valuation of around USD 2 billion.
February 2026: ENTOD launched COLLADERM, a transdermal collagen gel serum developed using AI-assisted bioengineering and recombinant vegan collagen.
February 2026: The FDA cleared Life Biosciences to begin a human trial of ER-100, an investigational gene therapy designed to partially restore youthful cellular function through epigenetic reprogramming.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Europe Clinical Trial Imaging Market Analysis, Trends, Forecast Up to 2034
Asia Pacific Clinical Trial Imaging Market Size, Share and Forecast to 2034
North America Clinical Laboratory Tests Market Analysis, Share to 2034
United States Healthcare Staffing Market Size, Share & Trends | Industry Report, 2034
United Kingdom Healthcare Staffing Market Size & Growth By 2034
United Arab Emirates Healthcare Staffing Market Size, Share & Trends | Industry Report, 2034
We are featured on:
sales@straitsresearch.com